Dermatology Times featured a JDD study on whether race plays a factor in access to biologics. The study, “No Racial Differences Found in Access to Biologics: A Population-Based Study of…
Healio featured a JDD study on the use of tildrakizumab for plaque psoriasis. Jayme Heim, MSN, FNP-BC, and colleagues wrote, “Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe…
By Allison Sit Healio recently reported on several JDD studies including one from the October JDD, “A Comparison of Alternative Medicine Users and Non-Users in Patients With Hidradenitis Suppurativa,” by…
NEW YORK, Jan. 25, 2022 /PRNewswire/ — WebMD Health Corp., an Internet Brands company and a leader in health information services for physicians, other healthcare professionals and consumers, today announced that it…
By Allison Sit Practical Dermatology published an article, “Survey: Consumers Interested in Medical Cannabis Products for Inflammatory Skin Disorders,” about the January JDD study, “Consumer Perspectives on and Utilization of…
By Allison Sit Healio recently reported on several JDD studies including one from the October JDD, “A Comparison of Alternative Medicine Users and Non-Users in Patients With Hidradenitis Suppurativa,” by…
By Allison Sit The Journal of Drugs in Dermatology is featured in the June issue of Dermatology Times. The publication included a 2020 JDD study in its article, “COVID-19 Increases…